Immune therapy trial for colon cancer using CD47 blockers
Part of Cancer, Digestive system clinical trials.
This trial studies an immune-based treatment that targets CD47 to help your immune system fight colon cancer. It may help by changing the “immune environment” around the tumor so it can be more effective, and it is aimed at people with colon cancer that is advanced, recurring, or needing surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You can understand the study and sign a consent form
- You have colon cancer that is advanced (metastatic), not advanced, or has come back and surgery is being proposed
- You are covered by a social security plan or are a beneficiary of one
- Your situation is not an emergency colon cancer surgery case
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests immune “checkpoint” medicines (and combinations) given before colon surgery to see if they can better control early colon cancer. It is aimed at people with non-metastatic colon cancer and certain tumor markers.
This trial tests a treatment made from your own immune cells (called TILs) that are taken from your tumor, grown in a lab, and given back to you along with immunotherapy. It is for people with advanced colon or rectum cancer who have run out of standard options.
This trial tests a personalized immune therapy (like a custom vaccine) for people with colorectal cancer that has a positive ctDNA MRD test after surgery. It aims to use the body's own immune system to target any remaining cancer cells and prevent the cancer from coming back.
This trial tests whether giving chemotherapy followed by an immunotherapy drug (a checkpoint inhibitor) before surgery helps shrink locally advanced colon cancer. It is for people with a specific tumor type (MSS and RAS mutation) who have not had prior treatment.
This trial tests whether adding a blood pressure medicine (propranolol) to immunotherapy and chemotherapy works better for locally advanced colon cancer. You would receive treatment before surgery to shrink your tumor.
This trial studies how the immune system responds to colon cancer, especially when it has spread. Researchers want to understand and possibly boost immune reactions during surgery. It may help find better ways to treat colorectal cancer in the future.
Hear when a new Cancer of the Colon trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.